Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Jazz Pharmaceuticals plc Director's Dealing 2014

Mar 3, 2014

30751_dirs_2014-03-03_a28fe743-34a2-4cc2-a389-ddcc672d02f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-02-27

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-27 Ordinary Shares M 11250 $46.83 Acquired 32582 Direct
2014-02-27 Ordinary Shares S 8000 $167.00 Disposed 24582 Direct
2014-02-27 Ordinary Shares S 3250 $166.20 Disposed 21332 Direct
2014-02-27 Ordinary Shares A 3750 Acquired 25082 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-27 Nonstatutory Stock Option (right to buy) $46.83 M 11250 Disposed 2022-08-08 Ordinary Shares (11250) Direct
2014-02-27 Nonstatutory Stock Option (right to buy) $166.62 A 6853 Acquired 2024-02-26 Ordinary Shares (6853) Direct
2014-02-27 Incentive Stock Option (right to buy) $166.62 A 647 Acquired 2024-02-26 Ordinary Shares (647) Direct

Footnotes

F1: Includes 257 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2013.

F2: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, February 27, 2014.

F3: This nonstatutory stock option is part of an option granted on August 9, 2012 that consisted of the nonstatutory stock option exercisable for 26,952 ordinary shares and an incentive stock option exercisable for 3,048 ordinary shares and has a vesting schedule of one fourth vested on August 9, 2013 and the remainder vesting in 36 equal monthly installments thereafter.

F4: These two options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these two options vest over four years measured from the grant date, February 27, 2014, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.